First, Do No Harm
Dimitrios Stefanoudakis(APLA Health), Alexandra Drakaki(University of California, Los Angeles), Allan J. Pantuck(University of California System)
Cited by 0
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2021|411
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
|JCI Insight|2017|129